HER2 Amplification Has No Prognostic Value in Sporadic and Hereditary Ovarian Tumours

Hereditary Cancer in Clinical Practice - United Kingdom
doi 10.1186/1897-4287-4-1-39
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Status of Her2 Amplification and Kras Mutations in Mucinous Ovarian Carcinoma

Human Genomics
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2016English

Up-Shoot in Adduction Has No Prognostic Value for Decompensation in Refractive Accommodative Esotropia

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2000English

Adverse Prognostic Impact of Intratumor Heterogeneous HER2 Gene Amplification in Patients With Esophageal Adenocarcinoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Expression Profile and Prognostic Value of SFN in Human Ovarian Cancer

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

Hereditary Multiple Glomus Tumours.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1986English

TGFβ Isoforms and Receptors mRNA Expression in Breast Tumours: Prognostic Value and Clinical Implications

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Comprehensive Analysis of Expression and Prognostic Value of Sirtuins in Ovarian Cancer

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

The Prognostic Value of Morphometry in Advanced Epithelial Ovarian Cancers

British Journal of Cancer
Cancer ResearchOncology
1995English

Prognostic Value of HMGA2, CDK4, and JUN Amplification in Well-Differentiated and Dedifferentiated Liposarcomas

Modern Pathology
Forensic MedicinePathology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy